Fabino Life Sciences Ltd.
BSE: 543444
₹20.31
₹0.96
(4.96%)
As on 27-Apr-2026IST
Market cap
₹4 Cr
Revenue (TTM)
₹18 Cr
P/E Ratio
69.8
P/B Ratio
1
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹0 Cr
-
ROE
1.5 %
-
ROCE
5.6 %
-
Industry P/E
30.84
-
EV/EBITDA
14.5
-
Debt to Equity
0.4
-
Book Value
₹20
-
EPS
₹0.3
-
Face value
10
-
Shares outstanding
2,100,000
7 Years Aggregate
CFO
₹-1.04 Cr
EBITDA
₹1.06 Cr
Net Profit
₹0.25 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Fabino Life Sci
| 29.4 | 38.2 | 39.1 | -23.4 | -13.1 | -- | -- |
|
BSE Healthcare*
| 18.8 | 2.8 | 8.7 | 17.1 | 23.1 | 14.8 | 12.4 |
|
Company
|
2025
|
|---|---|
|
Fabino Life Sci
| -52.2 |
|
BSE Small Cap
| -6.6 |
|
BSE Healthcare
| -3.3 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Fabino Life Sci
Manufacture of pharmaceuticals, medicinal chemical and botanical products
-
Incorporated
2011
-
Chairman
--
-
Managing Director
Aditya Jain
-
Headquarters
Sonipat, Haryana
-
Website
Looking for more details about Fabino Life Sciences Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Fabino Life Sci
What is the current share price of Fabino Life Sciences Ltd Today?
The share price of Fabino Life Sciences Ltd is ₹20.31 (BSE) as of 27-Apr-2026 IST. Fabino Life Sciences Ltd has given a return of -13.15% in the last 3 years.
What is the current PB & PE ratio of Fabino Life Sciences Ltd?
The P/E ratio of Fabino Life Sciences Ltd is 69.81 times as on 27-Apr-2026, a 126 premium to its peers’ median range of 30.84 times.
The P/B ratio of Fabino Life Sciences Ltd is 1.01 times as on 27-Apr-2026, a 84 discount to its peers’ median range of 6.38 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
84.19 |
1.22 |
2024 |
0.00 |
0.00 |
2023 |
583.66 |
1.53 |
2022 |
121.69 |
1.39 |
2021 |
0.00 |
0.00 |
What is the 52 Week High and Low of Fabino Life Sciences Ltd?
The 52-week high and low of Fabino Life Sciences Ltd are Rs 38.96 and Rs 13.01 as of 31-Aug-2026.
What is the market cap of Fabino Life Sciences Ltd?
Fabino Life Sciences Ltd has a market capitalisation of ₹ 4 Cr as on 27-Apr-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Fabino Life Sciences Ltd?
Before investing in Fabino Life Sciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.